Detalhe da pesquisa
1.
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation.
Int J Mol Sci
; 24(22)2023 Nov 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38003295